耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗感音神经性耳聋的效果

doi:10.3760/cma.j.cn441417-20250221-14030

国际医药卫生导报 ›› 2025, Vol. 31 ›› Issue (14): 2439-2443.DOI: 10.3760/cma.j.cn441417-20250221-14030

耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗感音神经性耳聋的效果

高彦斌¹ 韩宁² 李国徽¹

¹宁夏医科大学附属银川市中医医院眩晕病科，银川 750001；²宁夏医科大学附属银川市中医医院康复（脑病）科，银川 750001

收稿日期:2025-02-21 出版日期:2025-07-01 发布日期:2025-08-06
通讯作者: 高彦斌，Email：837700721@qq.com
基金资助:
宁夏医科大学科学研究资助项目（XM2023077）；银川市科技计划（2021-SF-003）

Effect of postauricular acupoint injection of methylprednisolone sodium succinate combined with modified Longdan Xiegan decoction in treatment of sensorineural hearing loss

Gao Yanbin¹, Han Ning², Li Guohui¹

¹Department of Vertigo Diseases, Yinchuan Hospital of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan 750001, China; ²Department of Rehabilitation (Brain Diseases), Yinchuan Hospital of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan 750001, China

Received:2025-02-21 Online:2025-07-01 Published:2025-08-06
Contact: Gao Yanbin, Email: 837700721@qq.com
Supported by:
Scientific Research Project Supported by Ningxia Medical University (XM2023077); Plan of Science and Technology in Yinchuan (2021-SF-003)

摘要/Abstract

摘要：

目的　探讨耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗感音神经性耳聋（SNHL）患者的效果。方法　选取2024年1月至9月在宁夏医科大学附属银川市中医医院眩晕病科治疗的SNHL患者60例进行随机对照试验。采用随机数字表法将其分为治疗组和对照组，各30例。治疗组男15例，女15例，年龄（49.53±10.38）岁，病程（6.43±2.33）个月。对照组男16例，女14例，年龄（49.63±10.11）岁，病程（6.30±2.35）个月。治疗组耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗，对照组口服甲钴胺片治疗，均连续用药4周。对比两组治疗前、治疗后纯音听阈测定、耳鸣残障量表评分、听性脑干反应Ⅰ波潜伏期、临床疗效与不良反应情况。统计学方法采用t检验、U检验、秩和检验、χ²检验。结果　治疗前及治疗后，治疗组患者纯音听阈测定［低频（0.5 kHz）、中频（1.0 kHz）、高频（2.0 kHz）］、耳鸣残障量表评分、听性脑干反应I波潜伏期分别为（57.33±13.16）dB、（31.83±6.94）dB、52.50（45.00，65.00）dB、34.50（27.00，37.00）dB、（53.73±10.99）dB、（24.73±4.78）dB、（53.07±13.18）分、（29.20±6.99）分、0（0，0.50）s、0（0，0.20）s；对照组上述指标分别为（56.10±12.27）dB、（33.77±7.68）dB、53.00（44.00，65.00）dB、34.00（27.75，41.25）dB、（53.83±1.49）dB、（31.96±1.68）dB、52.60（26.30，78.90）分、35.50（28.50，42.25）分、0.15（0，0.50）s、0.10（0，0.40）s；两组治疗前后上述指标比较，差异均有统计学意义（均P<0.05）。治疗组总有效率96.67%（29/30），高于对照组的90.00%（27/30），差异有统计学意义（χ²=4.250，P<0.05）。两组患者治疗期间总体耐受性良好，均未出现严重不良反应。结论　耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗SNHL患者效果显著，安全性好，可改善患者临床症状和听力状况。

关键词: 感音神经性耳聋, 甲泼尼龙琥珀酸钠, 龙胆泻肝汤加味, 穴位注射

Abstract:

Objective　To explore the effect of postauricular acupoint injection of methylprednisolone sodium succinate combined with modified Longdan Xiegan decoction in the treatment of patients with sensorineural hearing loss (SNHL). Methods　Sixty patients with SNHL treated in Department of Vertigo Diseases, Yinchuan Hospital of Traditional Chinese Medicine, Ningxia Medical University from January to September 2024 were selected for the randomized controlled trial, and were divided into a treatment group (30 cases) and a control group (30 cases) by the random number table method. In the treatment group, there 15 males and 15 females; they were (49.53±10.38) years old; their disease duration was (6.43±2.33) months. In the control group, there were 16 males and 14 females; they were (49.63±10.11) years old; their disease duration was (6.30±2.35) months. The treatment group took the postauricular acupoint injection of methylprednisolone sodium succinate and Longdan Xiegan decoction, and the control group methylcobalamin tablets, for 4 weeks. The pure tone hearing threshold measurement, scores of Tinnitus Assessment Scale, and auditory brainstem response I-wave latency before and after the treatment, clinical efficacies, and adverse reactions were compared between the two groups by t, U, rank sum, and χ² tests. Results　Before and after the treatment, the values of pure tone hearing threshold determination [low-frequency (0.5 kHz), middle-frequency (1.0 kHz), and high-frequency (2.0 kHz)], score of Tinnitus Assessment Scale, and auditory brainstem response I-wave latency in the treatment group were (57.33±13.16) dB, (31.83±6.94) dB, 52.50 (45.00, 65.00) dB, 34.50 (27.00, 37.00) dB, (53.73±10.99) dB, (24.73±4.78) dB, 53.07±13.18, 29.20±6.99, 0 (0, 0.50) s, and 0 (0, 0.20) s, respectively; and the above indicators in the control group were (56.10±12.27) dB, (33.77±7.68) dB, 53.00 (44.00, 65.00) dB, 34.00 (27.75, 41.25) dB, (53.83±1.49) dB, (31.96±1.68) dB, 52.60 (26.30, 78.90), 35.50 (28.50, 42.25), 0.15 (0, 0.50) s, and 0.10 (0, 0.40)s, respectively; there were statistical differences in the above indicators between before and after the treatment in both groups (all P<0.05). The total effective rate in the treatment group was higher than that in the control group [96.67% (29/30) vs. 90.00% (27/30)], with a statistical difference (χ²=4.250; P<0.05). The overall tolerability in both groups during the treatment was good, and no serious adverse reactions occurred. Conclusion　Postauricular acupoint injection of methylprednisolone sodium succinate combined with modified Longdan Xiegan decoction in the treatment of patients with SNHL is effective and safe, and can improve their clinical symptoms and hearing status.

Key words: Sensorineural hearing loss, , Methylprednisolone sodium succinate, , ModifiedLongdan Xiegan , decoction, , Acupuncture point injection

高彦斌韩宁李国徽.

耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗感音神经性耳聋的效果 [J]. 国际医药卫生导报, 2025, 31(14): 2439-2443.

Gao Yanbin, Han Ning, Li Guohui.

Effect of postauricular acupoint injection of methylprednisolone sodium succinate combined with modified Longdan Xiegan decoction in treatment of sensorineural hearing loss [J]. International Medicine and Health Guidance News, 2025, 31(14): 2439-2443.

参考文献

[1]祁吉,夏爽.感音神经性耳聋的影像学及病因学研究[J].中国医学影像技术, 2005(9): 1307-1311. DOI:10.3321/j.issn:1003-3289.2005.09.001.

[2]T/YCSZJXH-001-2022,"筛区穴"穴位注射技术操作规范[S].银川:银川市针灸学会团体标准, 2022.

[3]郑中立,郭敏,李哲生,等.耳鼻咽喉科诊断学[M]. 2版.北京:人民卫生出版社, 2006.

[4]陈芳,张勤颖,张秋静,等.合并感音神经性耳聋的遗传性内分泌代谢病研究进展[J].临床耳鼻咽喉头颈外科杂志, 2024, 38(1): 63-69. DOI:10.13201/j.issn.2096-7993.2024.01.010.

[5]金媛,陈森,孙宇.先天性巨细胞病毒感染相关耳聋研究进展[J].中华耳科学杂志,2021,19(6): 982-986. DOI:10.3969/j.issn.1672-2922.2021.06.020.

[6]徐振华,王晓梅.中西医结合治疗氨基糖甙类药物中毒性耳聋32例临床分析[J].湖南中医杂志, 1996, (4): 16-17.

[7]王香香,孙建军,刁明芳.氧化应激在感音神经性耳聋中的作用机制[J].中国听力语言康复科学杂志,2023,21(1): 56-60. DOI:10.3969/j.issn.1672-4933.2023.01.014.

[8]陈晓剑,杨蓓蓓.感音神经性耳聋的相关因素分析及中西医结合治疗[J].中国现代医生, 2014, 52(12): 82-84.

[9]王新,梅凌云,蒋璐.鼓室硬化治疗的研究进展[J].临床耳鼻咽喉头颈外科杂志, 2024, 38(1): 86-90. DOI:10.13201/j.issn.2096-7993.2024.01.016.

[10]尹晓玲,火子榕,严爽,等.人工耳蜗植入与骨髓间充质干细胞移植联合治疗感音神经性耳聋研究进展[J].中华耳科学杂志, 2018, 16(2): 155-159. DOI: 10.3969/j.issn.1672-2922.2018.02.006.

[11]李瑞红.银杏叶提取物注射液联合声频共振耳聋治疗仪治疗神经性耳鸣耳聋的疗效观察[J].国际医药卫生导报, 2017, 23(22): 3559-3561. DOI:10.3760/cma.j.issn.1007-1245.2017.22.027.

[12]邵静雯,龚明杰,叶昀旖.清肝泻热针法联合通窍耳聋丸治疗肝胆火旺型突发性耳聋[J].吉林中医药, 2022, 42(10): 1219-1223. DOI:10.13463/j.cnki.jlzyy.2022.10.025.

[13]欧嘉胤,李颖,张悦,等.基于文献计量学和可视化工具的龙胆泻肝汤临床用药研究[J].世界科学技术-中医药现代化,2021,23(2): 587-596. DOI:10.11842/wst.20200918004.

[14]Syed AP, Greulich F, Ansari SA, et al. Anti-inflammatory glucocorticoid action: genomic insights and emerging concepts[J]. Curr Opin Pharmacol, 2020, 53: 35-44. DOI: 10.1016/j.coph.2020.03.003.

[15]Cain DW, Cidlowski JA. Immune regulation by glucocorticoids[J]. Nat Rev Immunol, 2017, 17(4): 233-247.

[16]Löwenberg M, Verhaar AP, van den Brink GR, et al. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression[J]. Trends Mol Med, 2007, 13(4): 158-163.

[17]陈郑礼,孙瑜,王俊杰,等. MIF抵抗糖皮质激素的抗炎效应及其机制[J].中国免疫学杂志, 2013, 29(11): 1146-1150. DOI:10.3969/j.issn.1000-484X.2013.11.005.

[18]Zhang DG, Yu WQ, Liu JH, et al. Serum/glucocorticoid-inducible kinase 1 deficiency induces NLRP3 inflammasome activation and autoinflammation of macrophages in a murine endolymphatic hydrops model[J]. Nat Commun, 2023, 14(1): 1249. DOI: 10.1038/s41467-023-36949-4.

[19]Herrera NA, Duchatsch F, Tardelli LP, et al. MicroRNA-126 upregulation, induced by training, plays a role in controlling microcirculation in dexamethasone treated rats [J]. Mol Cell Endocrinol, 2020, 505: 110732. DOI: 10.1016/j.mce.2020.110732.

[20]贾艳玫,杨延平,李向葵,等.耳后穴位注射治疗突发性耳鸣[J].耳鼻喉学报, 1998(3): 181-182.

[21]张玉杰,李佳慧.耳后筛区注射甲泼尼龙琥珀酸钠联合利多卡因在治疗突发性耳聋伴耳鸣中的效果[J].智慧健康, 2024, 10(33): 79-81,85. DOI:10.19335/j.cnki.2096-1219.2024.33.021.

[22]张锐,殷洪林,马懿飞,等.通草的本草考证及药理作用研究[J].亚太传统医药, 2023, 19(3): 178-182. DOI:10.11954/ytctyy.202303039.

[23]梁旗,张来宾,吕洁丽.川芎的化学成分和药理作用研究进展[J].新乡医学院学报, 2024, 41(3): 275-285. DOI:10.7683/xxyxyxb.2024.03.015.

[24]金杰,肖湘.王不留行的化学成分、药理作用及临床应用研究进展[J].中国药物经济学, 2022, 17(4): 124-128. DOI:10.12010/j.issn.1673-5846.2022.04.029.

[25]汪海英,蒋虎刚,王新强,等.地龙的临床应用及药理作用的研究进展[J].实用中医内科杂志, 2024, 38(12): 92-95. DOI:10.13729/j.issn.1671-7813.Z20240011.

[26]唐英,段晓欢,王宗杰.活血化瘀类中药在突发性耳聋中的应用[J].甘肃中医学院学报, 2008, 25(2): 49-52. DOI:10.3969/j.issn.1003-8450.2008.02.021.

耳后穴位注射甲泼尼龙琥珀酸钠联合龙胆泻肝汤加味治疗感音神经性耳聋的效果

Effect of postauricular acupoint injection of methylprednisolone sodium succinate combined with modified Longdan Xiegan decoction in treatment of sensorineural hearing loss

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 4

编辑推荐

Metrics

[1]	熊垚方长琳. 醒脑开窍针刺联合穴位注射治疗缺血性卒中上肢痉挛性瘫痪气虚血瘀证的效果 [J]. 国际医药卫生导报, 2024, 30(24): 4083-4086.
[2]	王海玲黄文通杨洁徐祉君王宗耀. 芩葶清肺汤联合双侧足三里穴位注射、穴位敷贴治疗痰热淤肺证AECOPD患者的疗效评价[J]. 国际医药卫生导报, 2022, 28(22): 3212-3216.
[3]	张少朋. 西医方案与益气扶正解毒汤+足三里穴位注射治疗晚期胃癌患者的临床效果[J]. 国际医药卫生导报, 2022, 28(21): 3032-3036.
[4]	于超生于锋邓海燕李军政黄昌锦李慧. 电针法、穴位注射法治疗突发性聋的临床疗效研究[J]. 国际医药卫生导报, 2022, 28(18): 2522-2527.